Johnson and Johnson consumer health unit Kenvue files for IPO Ruchika Sharma5 Jan 2023 12:15 PM ISTKenvue said J&J will continue to own at least 80.1% of the voting power of the company’s shares upon completion of the offering.
Abiomed now part of Johnson and Johnson Ruchika Sharma26 Dec 2022 2:15 PM ISTNew Brunswick: Johnson & Johnson has announced that the company has completed its acquisition of Abiomed, Inc. is now part of Johnson &...
Janssen seeks USFDA nod for Multiple myeloma treatment Talquetamab Ruchika Sharma11 Dec 2022 1:00 PM ISTRaritan, N.J.: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Biologics License Application...
Johnson & Johnson CEO Joaquin Duato elected as new Chairman of Board Ruchika Sharma2 Dec 2022 11:00 AM ISTNew Brunswick: Johnson & Johnson has announced that its Board of Directors has elected Chief Executive Officer, Joaquin Duato, to assume the...
Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara Ruchika Sharma1 Dec 2022 1:15 PM ISTIf Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.
Re-examine JnJ baby powder samples: HC directs Maharashtra govt Ruchika Sharma15 Nov 2022 1:30 PM IST"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution,” the court said.
Johnson and Johnson to acquire Abiomed for USD 16.6 billion to boost cardiovascular business Ruchika Sharma2 Nov 2022 12:30 PM ISTNew Brunswick: Johnson & Johnson and Abiomed have entered into a definitive agreement under which Johnson & Johnson will acquire through a...
Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma Ruchika Sharma29 Oct 2022 10:00 AM ISTTECVAYLI is a first-in-class, bispecific T-cell engager antibody that is administered as a subcutaneous treatment.
JnJ sells Telangana plant to Hetero for Rs 130 crore Ruchika Sharma18 Oct 2022 1:30 PM ISTThe facility will be Hetero's flagship sterile pharmaceutical and biologics manufacturing unit and will generate 2,000 new jobs, Hetero said in a...
Former JnJ executive Mathai Mammen emerges as top candidate to head Biogen as CEO: Report Ruchika Sharma8 Oct 2022 12:15 PM ISTVounatsos is serving as CEO until a successor is appointed.
Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment Ruchika Sharma28 Aug 2022 12:45 PM ISTChronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...
JnJ to stop manufacturing its talc based baby powder from 2023 Roshni Dhar13 Aug 2022 5:51 PM ISTJohnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended...
